Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor

Jingjing Zhao(Peking University), Hongkui Deng(National Institute of Biological Sciences, Beijing)
OncoImmunology
October 5, 2023
Cited by 8


Related Papers